All known *de novo* DNA methylation in Arabidopsis is carried out by DOMAINS REARRANGED METHYLASE2 (DRM2)[@R1],[@R2], a homolog of DNMT3 methyltransferases. DRM2 is guided by small interfering RNAs (siRNAs) in a pathway termed RNA-directed DNA methylation (RdDM)[@R3]. Current models suggest that the RNA polymerase IV (Pol IV) complex is recruited to a target sequences by an unknown mechanism resulting in the production of single-stranded RNA, which is converted into double-stranded RNA by RNA-DEPENDENT RNA POLYMERASE2 (RDR2) and subsequently processed by DICER-LIKE3 (DCL3) into 24 nucleotide siRNAs. siRNAs are then loaded into ARGONAUTE4 (AGO4) which interacts with the Pol V machinery which transcribes RNA at silent loci [@R4],[@R5]. AGO4-siRNA complexes are then thought to pair with nascent RNA transcripts to guide DRM2 to initial target loci[@R6]. In order to better understand RdDM, we performed a screen to identify mutants affecting *de novo* methylation using *FWA* silencing as a model.

The endogenous *FWA* gene is heritably silenced by methylation at two tandem repeats in its upstream region. Unmethylated *fwa* epialleles cause *FWA* ectopic expression resulting in a dominant late flowering phenotype that is easily scored[@R7]. In wild type plants, methylation of *FWA* transgenes is efficiently established, while RdDM mutants fail to methylate and silence *FWA* and therefore flower late. By screening for mutants affecting the establishment of silencing at *FWA* transgene, but that do not affect pre-existing silencing at the *FWA* endogene, one can screen for *de novo* methylation mutants[@R1],[@R2].

We screened a collection of 429 T-DNA insertion mutants using *FWA Agrobacterium*-mediated transformation. This collection includes RNA binding proteins, Agenet domain containing proteins, Jumonji domain containing proteins and other chromatin related proteins ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}). This screen identified two mutants that were late flowering after transformation, but showed normal flowering prior to transformation ([Figure 1a](#F1){ref-type="fig"}). We termed these mutants *involved in de novo1* and *2* (*idn1-1* and *idn2-1*). The late-flowering phenotype of these mutants was correlated with reduced methylation of the *FWA* transgenes as revealed by genomic bisulfite sequencing. Methylation was severely reduced in all DNA sequence contexts (CG, CHG, and CHH, where H = A, T, or C); however, pre-established CG methylation remained unaffected at the *FWA* endogenous gene ([Figure 1b](#F1){ref-type="fig"}).

Another gene that can be used to test for *de novo* methylation is *SUPPRESSOR OF drm1 drm2 cmt3* (*SDC*). *SDC* possesses seven tandem repeats in its promoter region. Hypomethylation at these repeats leads to overexpression of *SDC* and a characteristic morphological phenotype including curled leaves and short stature. All RdDM mutants tested so far fail to efficiently establish methylation at either *SDC* or *FWA* transgenes[@R8]. We found that the *idn* mutants also showed a reduced ability to establish silencing of incoming *SDC* transgenes. This was especially evident in the case of *idn1-1*. T~1~ *idn1-1* plants transformed with *SDC* showed a dramatic increase in *SDC* expression; on the other hand, *idn2-1* T~1~ transformants displayed nearly wild type *SDC* expression levels ([Figure 1c](#F1){ref-type="fig"}). *SDC* overexpression is correlated with moderate hypomethylation at *SDC* tandem repeats as assayed by bisulfite sequencing ([Figure 1c](#F1){ref-type="fig"}). These data reinforce that *IDN1 and IDN2* control *de novo* methylation.

Thus far all mutations known to block *de novo* methylation also affect maintenance of methylation at several loci[@R1],[@R2],[@R9]. We analyzed the methylation state of representative endogenous targets including the *MEA-ISR*, *5S*, *SDC* and *FWA* repeats using methylation sensitive enzymes coupled with Southern blots and/or bisulfite sequencing techniques. The *idn1-1* and *idn2-1* mutations both caused a reduction of non-CG methylation at *MEA-ISR* and *FWA* repeats ([Figure 1c](#F1){ref-type="fig"}, [Figure 2a and 2b](#F2){ref-type="fig"}). Furthermore, they showed reduced CG methylation at the *5S* loci and a minor reduction in CHH methylation at the *SDC* repeats ([Figure 2b and 2c](#F2){ref-type="fig"}). These methylation phenotypes are consistent with those seen in *drm2* and other RdDM mutants[@R3] suggesting that *IDN1* and *IDN2* play an important role in the RdDM pathway.

Because *SDC* silencing is redundantly controlled by both the RdDM and CMT3 pathways[@R8], we crossed the *idn* mutants to the null *CMT3* allele, *cmt3--11*. As previously reported for *drm1 drm2 cmt3* triple mutants[@R8], we observed strong *SDC* overexpression and the accompanying *SDC* morphological phenotype in the *idn1-1 cmt3--11* double mutant. However, the *idn2-1 cmt3--11* double mutant did not overexpress *SDC*. Consistently *idn1-1 cmt3--11* exhibited reduced CG and CHG methylation at *SDC*, whereas *idn2-1 cmt3--11* showed only a partial decrease in CHH methylation ([Figure 2b and 2c](#F2){ref-type="fig"}). These results suggest that *IDN1* plays a stronger or more general role in RdDM than *IDN2*.

To determine where the *idn* mutants act within the RdDM pathway, we examined siRNAs abundance at several loci. Comparison between the *idn* mutants and other RdDM pathway components showed that both *idn* mutants display normal (*SDC* and *siR02*) or slightly reduced (*FWA*, *AtSN1*, *MEA-ISR*, *5S* and *siR1003*) siRNAs levels, but they did not completely lack siRNAs as observed in *rdr2-1* or *nrpd1a* mutants ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). This suggests that *IDN1* and *IDN2* likely act downstream of initial siRNA biogenesis.

To gain further insight into the molecular mechanism of *de novo* methylation, we cloned both *IDN1* and *IDN2*. Since neither of the T-DNAs insertion co-segregated with the respective mutant phenotypes, we isolated both *IDN1* and *IDN2* genes using a map-based approach. The *idn* phenotype at *MEA-ISR* segregated in a Mendelian fashion in F~2~ L*er*×*idn* populations allowing us to follow the mutant phenotypes. Fine mapping strategies localized each mutation to a small genomic interval on Chromosome III ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). We identified *IDN1* and *IDN2* initially by DNA sequence mutations in these regions. The *idn1-1* allele carries a point mutation, whereas *idn2-1* allele carries a point mutation and a 24 base pair deletion. To confirm gene identification, we complemented *idn1-1* and *idn2-1* with genomic fragments containing wild type *IDN1* or *IDN2* respectively ([Supplementary Fig. 2b and 2c](#SD1){ref-type="supplementary-material"}). In addition, we characterized additional alleles of *IDN1* and *IDN2* obtained from available T-DNA collections ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}) and found similar methylation defects at the *5S* and *MEA-ISR* loci ([Figure 2a](#F2){ref-type="fig"}).

*IDN1* encodes DEFECTIVE IN MERISTEM SILENCING3 (DMS3=At3g49250), a previously described protein that shares homology with structural maintenance of chromosome (SMC) proteins[@R10]. The *dms3* alleles were show to be required for RdDM, and for the production of secondary siRNAs[@R10] as well as Pol V non-coding transcripts[@R6], consistent with a role of IDN1/DMS3 in a downstream part of the RNA directed *de novo* methylation pathway.

*IDN2* (*At3g48670*) encodes a predicted protein of 648 amino acids containing a zinc finger domain, and XS and XH domains separated by a coiled-coil region. An XS/XH protein family has been recently defined based on homology with the rice gene X and the protein SGS3 involved in posttranscriptional gene silencing[@R11],[@R12]. In addition to *IDN2*, there are related homologous genes in the Arabidopsis genome containing XS/XH domains including *At1g15910, At4g00380, At4g01780, At1g13790, At3g12550, At1g80790, At5g59390*, and *At4g01180*, and one or more of these might act redundantly with IDN2 and explain why the *idn2* loss-of-function phenotype is not as strong as that of *idn1*.

The XS domain has been predicted to be an RNA binding domain and regions around residues N16 and F64 are conserved between XS and RNP1/RNP2 functional motifs in RBPs[@R13]. Recently, it has been shown that SGS3 XS domain can bind 5' overhanging double stranded (dsRNA) species[@R14]. To test IDN2 RNA binding abilities we performed gel mobility shift assays using the XS and coiled-coiled domains, (IDN2ΔZnFΔXH), and several RNA species previously described[@R14]. Interestingly, IDN2ΔZnFΔXH showed specificity for dsRNAs possessing 5' overhangs ([Supplementary Figure 3](#SD1){ref-type="supplementary-material"}). Mutations at N16 and F64 abolished this binding, indicating that XS is the domain responsible for the RNA binding. While it is unclear what double stranded 5' overhang substrate might be involved in RdDM it is tempting to speculate that IDN2 could recognize an siRNA which is bound to its target non-coding RNA, facilitating the downstream targeting of chromatin factors such as DRM2 to methylation targets. While future studies will be required to determine the precise function of both IDN1 (DMS3) and IDN2, it is clear that they are critical factors in the RdDM pathway.
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![*De novo* methylation phenotype of *idn* mutants\
**a)** Flowering time measured as total number of leaves produced by wild type, *idn* mutants and *FWA* transformed T~1~ plants under long day conditions. Error bars depict standard deviation. **b)** Methylation status of wild type and *idn* mutants at endogenous and transgenic *FWA*. **c)** *SDC* expression levels in *idn* mutants before and after *SDC* transformation. Hybridization with a *UBQ10* probe is shown as loading control. Panel below shows methylation status of wild type and *idn* mutants at transgenic *SDC*.](nihms145409f1){#F1}

![Maintenance methylation phenotype of *idn* mutants\
**a)** Methylation sensitive enzyme Southern hybridization assay at *5S* and *MEA-ISR* loci, and *HaeIII* cutting assay at *AtSN1*. *HaeIII*, is blocked by C methylation in GGCC context, *HpaII* is blocked by C methylation in CCGG context and *MspI* is blocked by methylation of the external C in CCGG context. **b)** Methylation status of wild type, *idn* and *idn cmt3--11* double mutants at endogenous *SDC* and methylation status of wild type and *idn* mutants at *MEA-ISR*. **c)** Morphological and molecular phenotype of *idn cmt3--11* double mutants.](nihms145409f2){#F2}
